ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael C. Mauney
Irving L. Kron
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mauney, M. C.
Right arrow Articles by Kron, I. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mauney, M. C.
Right arrow Articles by Kron, I. L.

Ann Thorac Surg 1995;60:819-823
© 1995 The Society of Thoracic Surgeons


II: Surgical Myocardial Protection

The Physiologic Basis of Warm Cardioplegia

Michael C. Mauney, MD, Irving L. Kron, MD

Thoracic and Cardiovascular Division, Department of Surgery, University of Virginia Health Sciences Center, Charlottesville, Virginia

Abstract

Background. Advances in myocardial protection have been instrumental in making cardiac surgery safer. Debate exists over the optimal medium and the optimal temperature for cardioplegia. Currently blood cardioplegia is preferred over crystalloid; the optimal temperature, however, remains controversial.

Methods. Both warm and cold blood cardioplegia use potassium-induced electromechanical arrest, thereby reducing oxygen consumption by 90% in the working heart. Hypothermic blood cardioplegia given every 15 to 30 minutes provides a bloodless operative field and reduces oxygen consumption an additional 5% to 20%. Continuous warm cardioplegia avoids the deleterious effects of hypothermic ischemia and minimizes reperfusion injury. Perfusion is often interrupted for 5 to 10 minutes to allow adequate visualization of the operative site. Both warm and cold cardioplegia can be given either antegrade or retrograde.

Results. Retrospective studies from Toronto support the safety and efficacy of warm cardioplegia. Two large prospective, randomized trials of warm cardioplegia versus intermittent cold blood or cold crystalloid cardioplegia demonstrated equally low incidences of death, perioperative myocardial infarction, and need of intraaortic balloon pump support.

Conclusions. Warm blood cardioplegia represents the latest development in myocardial protection. Preliminary studies support its efficacy. Additional studies are needed to determine the ideal route of delivery and to identify any risks associated with the inherent warm cardiopulmonary bypass required.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
V. Venugopal, A. Ludman, D. M. Yellon, and D. J. Hausenloy
'Conditioning' the heart during surgery
Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 977 - 987.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Wang, H. Liu, B. Xiang, G. Li, M. Gruwel, M. Jackson, B. Tomanek, T. A. Salerno, R. Deslauriers, and G. Tian
Keeping the heart empty and beating improves preservation of hypertrophied hearts for valve surgery
J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1314 - 1320.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. M. Scarabelli, E. Pasini, G. Ferrari, M. Ferrari, A. Stephanou, K. Lawrence, P. Townsend, C. Chen-Scarabelli, G. Gitti, L. Saravolatz, et al.
Warm blood cardioplegic arrest induces mitochondrial-mediated cardiomyocyte apoptosis associated with increased urocortin expression in viable cells
J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 364 - 371.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Matsumoto, G. Watanabe, M. Endo, H. Sasaki, F. Kasashima, and I. Kosugi
Efficacy and safety of on-pump beating heart surgery for valvular disease
Ann. Thorac. Surg., September 1, 2002; 74(3): 678 - 683.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
R. Ascione, M. Caputo, W.J. Gomes, A.A. Lotto, A.J. Bryan, G.D. Angelini, and M.-S. Suleiman
Myocardial injury in hypertrophic hearts of patients undergoing aortic valve surgery using cold or warm blood cardioplegia
Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 440 - 446.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. M. Weman, P. J. Karhunen, A. Penttila, A. A. Jarvinen, and U.-S. Salminen
Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting
Ann. Thorac. Surg., September 1, 2000; 70(3): 807 - 812.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Minatoya, H. Okabayashi, I. Shimada, A. Tanabe, T. Nishina, K. Nandate, and M. Kunihiro
Intermittent antegrade warm blood cardioplegia for CABG: extended interval of cardioplegia
Ann. Thorac. Surg., January 1, 2000; 69(1): 74 - 76.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Caputo, R. Ascione, G. D. Angelini, M-S. Suleiman, and A. J. Bryan
The end of the cold era: from intermittent cold to intermittent warm blood cardioplegia
Eur. J. Cardiothorac. Surg., November 1, 1999; 14(5): 467 - 475.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. M.F. Elwatidy, M. A. Fadalah, E. A. Bukhari, K. A. Aljubair, A. Syed, A. K. Ashmeg, and M. R. Alfagih
Antegrade crystalloid cardioplegia vs antegrade/retrograde cold and tepid blood cardioplegia in CABG
Ann. Thorac. Surg., August 1, 1999; 68(2): 447 - 453.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. J. Cook
Changing Temperature Management for Cardiopulmonary Bypass
Anesth. Analg., June 1, 1999; 88(6): 1254 - 1254.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. P. Tritto, J. Inserte, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler
Sodium/Hydrogen Exchanger Inhibition Reduces Myocardial Reperfusion Edema After Normothermic Cardioplegia
J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 709 - 715.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. A. Rivetti and S. M. A. Gandra
Initial Experience Using an Intraluminal Shunt During Revascularization of the Beating Heart
Ann. Thorac. Surg., June 1, 1997; 63(6): 1742 - 1747.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
D. D. Belke, L. C. H. Wang, and G. D. Lopaschuk
Effects of hypothermia on energy metabolism in rat and Richardson's ground squirrel hearts
J Appl Physiol, April 1, 1997; 82(4): 1210 - 1218.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.